Response: Physostigmine May Not Be the Only Option for Treating Anticholinergic Syndrome
Crossref DOI link: https://doi.org/10.1007/s13181-014-0443-y
Published Online: 2014-10-21
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pluim, Thomas
Text and Data Mining valid from 2014-10-21